At a glance
ClinicalIndex Comparison RecordN/ACompleted· 275 enrolled
Drug / intervention
truFreeze Spray Cryotherapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
trūFreeze® Spray Cryotherapy Patient Registry
In Brief
An observational study evaluating truFreeze Spray Cryotherapy for Barrett Esophagus and 5 related conditions. Completed, enrolled 275 participants across 16 sites.
Detailed Summary
To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBarrett Esophagus, Esophageal Dysplasia, Esophageal Neoplasm, Esophageal Stenosis, Bronchial Neoplasm, Stenosis of Bronchus or Trachea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 2013
Enrollment StartApr 2013
Primary CompletionJan 2022
Study CompletionApr 2022
TodayJul 2026
First PostedMar 1, 2013
Enrollment StartApr 1, 2013
Primary CompletionJan 1, 2022
Study CompletionApr 1, 2022
TodayJul 2, 2026
Enrollment to primary: 8.8 yearsPosted 13.3 years ago
Interventions
truFreeze Spray Cryotherapydevice
spray cryotherapy